Growth Metrics

Omeros (OMER) Current Assets (2010 - 2026)

Omeros recorded quarterly Current Assets of $180.4 million in Q1 2026, down 16.37% quarter-over-quarter from $215.7 million in Q4 2025, and up 87.52% year-over-year from $96.2 million in Q1 2025.

Omeros' Current Assets history runs 17 years deep, the most recent figure standing at $180.4 million for Q1 2026.

  • In Q1 2026, Current Assets rose 87.52% year-over-year to $180.4 million; the TTM figure through Mar 2026 stood at $180.4 million (up 87.52% YoY), while the FY2025 annual figure was $215.7 million, up 60.8% from the prior year.
  • Current Assets came in at $180.4 million for Q1 2026 at Omeros, down from $215.7 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $443.2 million in Q4 2022 to a low of $69.6 million in Q2 2025.
  • A 5-year average of $230.9 million and a median of $210.2 million in 2022 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets soared 215.87% in 2022 and tumbled 65.77% in 2025, its largest moves.
  • Omeros' Current Assets stood at $443.2 million in 2022, then slumped by 50.84% to $217.9 million in 2023, then slumped by 38.45% to $134.1 million in 2024, then soared by 60.8% to $215.7 million in 2025, then slipped by 16.37% to $180.4 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $180.4 million, $215.7 million, and $71.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 10.37 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 37.31 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 73.04 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 11.73 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.21 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.22 Bn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 180.36 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 180.36 Mn
Dec 31, 2025 215.67 Mn
Sep 30, 2025 71.81 Mn
Jun 30, 2025 69.65 Mn
Mar 31, 2025 96.18 Mn
Dec 31, 2024 134.12 Mn
Sep 30, 2024 164.92 Mn
Jun 30, 2024 202.93 Mn
Mar 31, 2024 280.96 Mn
Dec 31, 2023 217.90 Mn
Sep 30, 2023 351.34 Mn
Jun 30, 2023 388.56 Mn
Mar 31, 2023 417.04 Mn
Dec 31, 2022 443.24 Mn
Sep 30, 2022 288.55 Mn
Jun 30, 2022 192.72 Mn
Mar 31, 2022 210.22 Mn
Dec 31, 2021 247.96 Mn
Sep 30, 2021 91.35 Mn
Jun 30, 2021 112.40 Mn
Mar 31, 2021 132.48 Mn
Dec 31, 2020 151.29 Mn
Sep 30, 2020 195.99 Mn
Jun 30, 2020 38.93 Mn
Mar 31, 2020 85.61 Mn
Dec 31, 2019 103.75 Mn
Sep 30, 2019 63.80 Mn
Jun 30, 2019 65.94 Mn
Mar 31, 2019 76.87 Mn
Dec 31, 2018 89.87 Mn
Sep 30, 2018 66.00 Mn
Jun 30, 2018 96.50 Mn
Mar 31, 2018 78.68 Mn
Dec 31, 2017 108.37 Mn
Sep 30, 2017 117.90 Mn
Jun 30, 2017 53.09 Mn
Mar 31, 2017 51.35 Mn
Dec 31, 2016 60.26 Mn
Sep 30, 2016 60.65 Mn
Jun 30, 2016 34.11 Mn
Mar 31, 2016 24.32 Mn
Dec 31, 2015 37.15 Mn
Sep 30, 2015 39.46 Mn
Jun 30, 2015 56.68 Mn
Mar 31, 2015 73.07 Mn
Dec 31, 2014 9.04 Mn
Sep 30, 2014 23.36 Mn
Jun 30, 2014 38.97 Mn
Mar 31, 2014 54.13 Mn
Dec 31, 2013 14.82 Mn
Sep 30, 2013 10.27 Mn
Jun 30, 2013 21.27 Mn
Mar 31, 2013 15.81 Mn
Dec 31, 2012 24.70 Mn
Sep 30, 2012 31.44 Mn
Jun 30, 2012 8.52 Mn
Mar 31, 2012 19.70 Mn
Dec 31, 2011 25.95 Mn
Sep 30, 2011 33.84 Mn
Jun 30, 2011 39.67 Mn
Dec 31, 2010 43.75 Mn